These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37940395)

  • 1. Leveraging human immune organoids for rational vaccine design.
    Kastenschmidt JM; Sureshchandra S; Wagar LE
    Trends Immunol; 2023 Dec; 44(12):938-944. PubMed ID: 37940395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids.
    Kastenschmidt JM; Sureshchandra S; Jain A; Hernandez-Davies JE; de Assis R; Wagoner ZW; Sorn AM; Mitul MT; Benchorin AI; Levendosky E; Ahuja G; Zhong Q; Trask D; Boeckmann J; Nakajima R; Jasinskas A; Saligrama N; Davies DH; Wagar LE
    Immunity; 2023 Aug; 56(8):1910-1926.e7. PubMed ID: 37478854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
    Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
    PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection.
    Jang YH; Seong BL
    Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
    Calzas C; Chevalier C
    Front Immunol; 2019; 10():1605. PubMed ID: 31379823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.
    Cho A; Wrammert J
    Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and adaptive immunity toward influenza B viruses.
    Hensen L; Kedzierska K; Koutsakos M
    Future Microbiol; 2020 Jul; 15():1045-1058. PubMed ID: 32811172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Quest for a Truly Universal Influenza Vaccine.
    Jang YH; Seong BL
    Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The race toward a universal influenza vaccine: Front runners and the future directions.
    Hu L; Lao G; Liu R; Feng J; Long F; Peng T
    Antiviral Res; 2023 Feb; 210():105505. PubMed ID: 36574905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Quest for a Universal Flu Vaccine: Headless HA 2.0.
    Krammer F
    Cell Host Microbe; 2015 Oct; 18(4):395-7. PubMed ID: 26468743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.
    Whittle JR; Wheatley AK; Wu L; Lingwood D; Kanekiyo M; Ma SS; Narpala SR; Yassine HM; Frank GM; Yewdell JW; Ledgerwood JE; Wei CJ; McDermott AB; Graham BS; Koup RA; Nabel GJ
    J Virol; 2014 Apr; 88(8):4047-57. PubMed ID: 24501410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protective immune responses elicited by live attenuated influenza vaccines.
    Jang YH; Seong BL
    Yonsei Med J; 2013 Mar; 54(2):271-82. PubMed ID: 23364956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.